{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T19:59:28Z","timestamp":1768679968178,"version":"3.49.0"},"reference-count":114,"publisher":"Bentham Science Publishers Ltd.","issue":"23","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPD"],"published-print":{"date-parts":[[2023,9,6]]},"abstract":"<jats:sec><jats:title>Abstract:<\/jats:title><jats:p>Coronary artery disease remains a condition with high prevalence and detrimental effects on the quality of life of affected individuals. Its most frequent manifestation, stable angina pectoris, may be challenging to manage despite the available antianginal pharmacotherapy and adequate risk factor control, especially in subjects not amenable to revascularization. In the direction of refractory angina pectoris, several approaches have been developed over the years with varying degrees of success. Among the most recognized techniques in managing angina is enhanced external counterpulsation, which utilizes mechanical compression of the lower extremities to increase blood flow to the heart. Moving to coronary sinus reduction, it leads to an increase in coronary sinus backward pressure, ultimately augmenting myocardial blood flow redistribution to ischemic regions and ameliorating chronic angina. Clinical trial results of the above-mentioned techniques have been encouraging but are based on small sample sizes to justify their widespread application. Other interventional approaches, such as transmyocardial laser revascularization, extracorporeal shockwave myocardial revascularization, and spinal cord stimulation, have been met with either controversial or negative results, and their use is not recommended. Lastly, angiogenic therapy with targeted intramyocardial vascular endothelial growth factor injection or CD34+ cell therapy may be beneficial and warrants further investigation. In this review, we summarize the current knowledge in the field of angina management, highlighting the potential and the gaps in the existing evidence that ought to be addressed in future larger-scale, randomized studies before these techniques can be safely adapted in the clinical practice of patients with refractory angina pectoris.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1381612829666230512152153","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T05:56:12Z","timestamp":1684130172000},"page":"1825-1834","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Novel Concepts in the Management of Angina in Coronary Artery Disease"],"prefix":"10.2174","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9260-6306","authenticated-orcid":true,"given":"Panagiotis","family":"Theofilis","sequence":"first","affiliation":[{"name":"1st Cardiology Department, \u201cHippokration\u201d General Hospital, University of Athens Medical School, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelos","family":"Oikonomou","sequence":"additional","affiliation":[{"name":"3rd Cardiology Department, &#34;Sotiria&#34; Chest Diseases Hospital, University of Athens Medical School, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marios","family":"Sagris","sequence":"additional","affiliation":[{"name":"1st Cardiology Department, \u201cHippokration\u201d General Hospital, University of Athens Medical School, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Papageorgiou","sequence":"additional","affiliation":[{"name":"Electrophysiology Department, Barts Heart Centre, St. Bartholomew's Hospital, West Smithfield, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Tsioufis","sequence":"additional","affiliation":[{"name":"1st Cardiology Department, \u201cHippokration\u201d General Hospital, University of Athens Medical School, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitris","family":"Tousoulis","sequence":"additional","affiliation":[{"name":"1st Cardiology Department, \u201cHippokration\u201d General Hospital, University of Athens Medical School, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"16812","DOI":"10.1002\/jcp.28350","volume":"234","author":"Malakar A.K.","year":"2019","unstructured":"Malakar A.K.; Choudhury D.; Halder B.; Paul P.; Uddin A.; Chakraborty S.; A review on coronary artery disease, its risk factors, and therapeutics. J Cell Physiol 2019,234(10),16812-16823","journal-title":"J Cell Physiol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1001\/jamacardio.2021.5613","volume":"7","author":"Lee Y.T.H.","year":"2022","unstructured":"Lee Y.T.H.; Fang J.; Schieb L.; Park S.; Casper M.; Gillespie C.; Prevalence and trends of coronary heart disease in the United States, 2011 to 2018. JAMA Cardiol 2022,7(4),459-462","journal-title":"JAMA Cardiol"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/cvr\/cvab264","volume":"118","author":"Sagris M.","year":"2021","unstructured":"Sagris M.; Antonopoulos A.S.; Theofilis P.; Risk factors profile of young and older patients with Myocardial Infarction. Cardiovasc Res 2021,118(10),2281-2292","journal-title":"Cardiovasc Res"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"6607","DOI":"10.3390\/ijms22126607","volume":"22","author":"Sagris M.","year":"2021","unstructured":"Sagris M.; Theofilis P.; Antonopoulos A.S.; Tsioufis C.; Oikonomou E.; Antoniades C.; Crea F.; Kaski J.C.; Tousoulis D.; Inflammatory mechanisms in COVID-19 and atherosclerosis: Current pharmaceutical perspectives. Int J Mol Sci 2021,22(12),6607","journal-title":"Int J Mol Sci"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3390\/biomedicines9070781","volume":"9","author":"Theofilis P.","year":"2021","unstructured":"Theofilis P.; Sagris M.; Oikonomou E.; Antonopoulos A.S.; Siasos G.; Tsioufis C.; Tousoulis D.; Inflammatory mechanisms contributing to endothelial dysfunction. Biomedicines 2021,9(7),781","journal-title":"Biomedicines"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1681\/ASN.2014040393","volume":"26","author":"Saab K.R.","year":"2015","unstructured":"Saab K.R.; Kendrick J.; Yracheta J.M.; Lanaspa M.A.; Pollard M.; Johnson R.J.; New insights on the risk for cardiovascular disease in African Americans: The role of added sugars. J Am Soc Nephrol 2015,26(2),247-257","journal-title":"J Am Soc Nephrol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"e2112800","DOI":"10.1001\/jamanetworkopen.2021.12800","volume":"4","author":"Blumenthal D.M.","year":"2021","unstructured":"Blumenthal D.M.; Howard S.E.; Searl Como J.; O\u2019Keefe S.M.; Atlas S.J.; Horn D.M.; Wagle N.W.; Wasfy J.H.; Yeh R.W.; Metlay J.P.; Prevalence of angina among primary care patients with coronary artery disease. JAMA Netw Open 2021,4(6),e2112800","journal-title":"JAMA Netw Open"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1001\/jama.2021.1527","volume":"325","author":"Joshi P.H.","year":"2021","unstructured":"Joshi P.H.; de Lemos J.A.; Diagnosis and management of stable angina. JAMA 2021,325(17),1765-1778","journal-title":"JAMA"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","volume":"41","author":"Knuuti J.","year":"2020","unstructured":"Knuuti J.; Wijns W.; Saraste A.; Capodanno D.; Barbato E.; Funck-Brentano C.; Prescott E.; Storey R.F.; Deaton C.; Cuisset T.; Agewall S.; Dickstein K.; Edvardsen T.; Escaned J.; Gersh B.J.; Svitil P.; Gilard M.; Hasdai D.; Hatala R.; Mahfoud F.; Masip J.; Muneretto C.; Valgimigli M.; Achenbach S.; Bax J.J.; Neumann F-J.; Sechtem U.; Banning A.P.; Bonaros N.; Bueno H.; Bugiardini R.; Chieffo A.; Crea F.; Czerny M.; Delgado V.; Dendale P.; Flachskampf F.A.; Gohlke H.; Grove E.L.; James S.; Katritsis D.; Landmesser U.; Lettino M.; Matter C.M.; Nathoe H.; Niessner A.; Patrono C.; Petronio A.S.; Pettersen S.E.; Piccolo R.; Piepoli M.F.; Popescu B.A.; R\u00e4ber L.; Richter D.J.; Roffi M.; Roithinger F.X.; Shlyakhto E.; Sibbing D.; Silber S.; Simpson I.A.; Sousa-Uva M.; Vardas P.; Witkowski A.; Zamorano J.L.; Achenbach S.; Agewall S.; Barbato E.; Bax J.J.; Capodanno D.; Cuisset T.; Deaton C.; Dickstein K.; Edvardsen T.; Escaned J.; Funck-Brentano C.; Gersh B.J.; Gilard M.; Hasdai D.; Hatala R.; Mahfoud F.; Masip J.; Muneretto C.; Prescott E.; Saraste A.; Storey R.F.; Svitil P.; Valgimigli M.; Windecker S.; Aboyans V.; Baigent C.; Collet J-P.; Dean V.; Delgado V.; Fitzsimons D.; Gale C.P.; Grobbee D.; Halvorsen S.; Hindricks G.; Iung B.; J\u00fcni P.; Katus H.A.; Landmesser U.; Leclercq C.; Lettino M.; Lewis B.S.; Merkely B.; Mueller C.; Petersen S.; Petronio A.S.; Richter D.J.; Roffi M.; Shlyakhto E.; Simpson I.A.; Sousa-Uva M.; Touyz R.M.; Benkhedda S.; Metzler B.; Sujayeva V.; Cosyns B.; Kusljugic Z.; Velchev V.; Panayi G.; Kala P.; Haahr-Pedersen S.A.; Kabil H.; Ainla T.; Kaukonen T.; Cayla G.; Pagava Z.; Woehrle J.; Kanakakis J.; T\u00f3th K.; Gudnason T.; Peace A.; Aronson D.; Riccio C.; Elezi S.; Mirrakhimov E.; Hansone S.; Sarkis A.; Babarskiene R.; Beissel J.; Maempel A.J.C.; Revenco V.; de Grooth G.J.; Pejkov H.; Julieb\u00f8 V.; Lipiec P.; Santos J.; Chioncel O.; Duplyakov D.; Bertelli L.; Dikic A.D.; Studen\u010dan M.; Bunc M.; Alfonso F.; B\u00e4ck M.; Zellweger M.; Addad F.; Yildirir A.; Sirenko Y.; Clapp B.; 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2020,41(3),407-477","journal-title":"Eur Heart J"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ijcard.2009.09.538","volume":"147","author":"Andr\u00e9ll P.","year":"2011","unstructured":"Andr\u00e9ll P.; Ekre O.; Grip L.; W\u00e4hrborg P.; Albertsson P.; Eliasson T.; Jeppsson A.; Mannheimer C.; Fatality, morbidity and quality of life in patients with refractory angina pectoris. Int J Cardiol 2011,147(3),377-382","journal-title":"Int J Cardiol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1136\/hrt.2003.025031","volume":"90","author":"DeJongste M.J.L.","year":"2004","unstructured":"DeJongste M.J.L.; Tio R.A.; Foreman R.D.; Chronic therapeutically refractory angina pectoris. Br Heart J 2004,90(2),225-230","journal-title":"Br Heart J"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"e003196","DOI":"10.1161\/JAHA.116.003196","volume":"5","author":"Rayner-Hartley E.","year":"2016","unstructured":"Rayner-Hartley E.; Sedlak T.; Ranolazine: A contemporary review. J Am Heart Assoc 2016,5(3),e003196","journal-title":"J Am Heart Assoc"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1001\/jama.297.16.1775","volume":"297","author":"Morrow D.A.","year":"2007","unstructured":"Morrow D.A.; Scirica B.M.; Karwatowska-Prokopczuk E.; Murphy S.A.; Budaj A.; Varshavsky S.; Wolff A.A.; Skene A.; McCabe C.H.; Braunwald E.; Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: The MERLIN- TIMI 36 randomized trial. JAMA 2007,297(16),1775-1783","journal-title":"JAMA"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1161\/CIRCULATIONAHA.110.937136","volume":"122","author":"Scirica B.M.","year":"2010","unstructured":"Scirica B.M.; Braunwald E.; Belardinelli L.; Hedgepeth C.M.; Spinar J.; Wang W.; Qin J.; Karwatowska-Prokopczuk E.; Verheugt F.W.A.; Morrow D.A.; Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: Observations from the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndrome-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) randomized controlled trial. Circulation 2010,122(5),455-462","journal-title":"Circulation"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1161\/CIRCULATIONAHA.107.763912","volume":"119","author":"Morrow D.A.","year":"2009","unstructured":"Morrow D.A.; Scirica B.M.; Chaitman B.R.; McGuire D.K.; Murphy S.A.; Karwatowska-Prokopczuk E.; McCabe C.H.; Braunwald E.; Evaluation of the glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trial. Circulation 2009,119(15),2032-2039","journal-title":"Circulation"},{"key":"ref=16","first-page":"e354","volume":"126","author":"Fihn S.D.","year":"2012","unstructured":"Fihn S.D.; Gardin J.M.; Abrams J.; Berra K.; Blankenship J.C.; Dallas A.P.; Douglas P.S.; Foody J.M.; Gerber T.C.; Hinderliter A.L.; King S.B.; Kligfield P.D.; Krumholz H.M.; Kwong R.Y.; Lim M.J.; Linderbaum J.A.; Mack M.J.; Munger M.A.; Prager R.L.; Sabik J.F.; Shaw L.J.; Sikkema J.D.; Smith C.R.; Smith S.C.; Spertus J.A.; Williams S.V.; Anderson J.L.; 2012 ACCF\/AHA\/ACP\/ AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: A report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular nurses association, society for cardiovascular angiography and interventions, and society of thoracic surgeons. Circulation 2012,126(25),e354-e471","journal-title":"Circulation"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1161\/CIRCULATIONAHA.109.923482","volume":"122","author":"Braith R.W.","year":"2010","unstructured":"Braith R.W.; Conti C.R.; Nichols W.W.; Choi C.Y.; Khuddus M.A.; Beck D.T.; Casey D.P.; Enhanced external counterpulsation improves peripheral artery flow-mediated dilation in patients with chronic angina: A randomized sham-controlled study. Circulation 2010,122(16),1612-1620","journal-title":"Circulation"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"590585","DOI":"10.3389\/fphys.2020.590585","volume":"11","author":"Liang J.","year":"2021","unstructured":"Liang J.; Shi J.; Wei W.; Wu G.; External counterpulsation attenuates hypertensive vascular injury through enhancing the function of endothelial progenitor cells. Front Physiol 2021,11,590585","journal-title":"Front Physiol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"e0151822","DOI":"10.1371\/journal.pone.0151822","volume":"11","author":"Qin X.","year":"2016","unstructured":"Qin X.; Deng Y.; Wu D.; Yu L.; Huang R.; Does enhanced external counterpulsation (EECP) significantly affect myocardial perfusion?: A systematic review and meta-analysis. PLoS One 2016,11(4),e0151822","journal-title":"PLoS One"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.hlc.2016.04.013","volume":"25","author":"Ahlbom M.","year":"2016","unstructured":"Ahlbom M.; Hagerman I.; St\u00e5hlberg M.; Manouras A.; F\u00f6rstedt G.; Wu E.; Lund L.H.; Increases in cardiac output and oxygen consumption during enhanced external counterpulsation. Heart Lung Circ 2016,25(11),1133-1136","journal-title":"Heart Lung Circ"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1007\/s11517-019-02028-4","volume":"57","author":"Li B.","year":"2019","unstructured":"Li B.; Wang W.; Mao B.; Yang H.; Niu H.; Du J.; Li X.; Liu Y.; Long-term hemodynamic mechanism of enhanced external counterpulsation in the treatment of coronary heart disease: A geometric multiscale simulation. Med Biol Eng Comput 2019,57(11),2417-2433","journal-title":"Med Biol Eng Comput"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"e0230144","DOI":"10.1371\/journal.pone.0230144","volume":"15","author":"Xu L.","year":"2020","unstructured":"Xu L.; Chen X.; Cui M.; Ren C.; Yu H.; Gao W.; Li D.; Zhao W.; The improvement of the shear stress and oscillatory shear index of coronary arteries during Enhanced External Counterpulsation in patients with coronary heart disease. PLoS One 2020,15(3),e0230144","journal-title":"PLoS One"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10557-020-07140-4","volume":"36","author":"Wang Y.","year":"2022","unstructured":"Wang Y.; Xu D.; The effect of enhanced external counterpulsation on platelet aggregation in patients with coronary heart disease. Cardiovasc Drugs Ther 2022,36(2),263-269","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/S0735-1097(99)00140-0","volume":"33","author":"Arora R.R.","year":"1999","unstructured":"Arora R.R.; Chou T.M.; Jain D.; Fleishman B.; Crawford L.; McKiernan T.; Nesto R.W.; The multicenter study of enhanced external counterpulsation (MUST-EECP): Effect of EECP on exercise-induced myocardial ischemia and anginal episodes. J Am Coll Cardiol 1999,33(7),1833-1840","journal-title":"J Am Coll Cardiol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/14017431.2014.994028","volume":"49","author":"May O.","year":"2015","unstructured":"May O.; Lynggaard V.; Mortensen J.C.A.; Malczynski J.; Enhanced external counterpulsation \u2013 Effect on angina pectoris, QoL and exercise capacity after 1 year. Scand Cardiovasc J 2015,49(1),1-6","journal-title":"Scand Cardiovasc J"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/MJT.0b013e31814db0ba","volume":"16","author":"Kumar A.","year":"2009","unstructured":"Kumar A.; Aronow W.S.; Vadnerkar A.; Sidhu P.; Mittal S.; Kasliwal R.R.; Trehan N.; Effect of enhanced external counterpulsation on clinical symptoms, quality of life, 6-minute walking distance, and echocardiographic measurements of left ventricular systolic and diastolic function after 35 days of treatment and at 1-year follow up in 47 patients with chronic refractory angina pectoris. Am J Ther 2009,16(2),116-118","journal-title":"Am J Ther"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"265","DOI":"10.34172\/jcvtr.2021.50","volume":"13","author":"Rayegani S.M.","year":"2021","unstructured":"Rayegani S.M.; Heidari S.; Maleki M.; Seyed-Nezhad M.; Heidari M.; Parhizgar S.E.; Moradi-Joo M.; Safety and effectiveness of enhanced external counterpulsation (EECP) in refractory angina patients: A systematic reviews and meta-analysis. J Cardiovasc Thorac Res 2021,13(4),265-276","journal-title":"J Cardiovasc Thorac Res"},{"key":"ref=28","first-page":"593","volume":"10","author":"Ziad S.","year":"2020","unstructured":"Ziad S.; Malik J.; Isiguzo O.; Xu L.; Chen L.; Cox A.; Shah S.A.; EECP improves markers of functional capacity regardless of underlying ranolazine therapy. Am J Cardiovasc Dis 2020,10(5),593-601","journal-title":"Am J Cardiovasc Dis"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"199","DOI":"10.5455\/medarh.2020.74.199-204","volume":"74","author":"Shaker S.","year":"2020","unstructured":"Shaker S.; Amran F.; Fatima G.; Aubaid H.; Hadi N.; Trimetazidine improves the outcome of EECP therapy in patients with refractory angina pectoris. Med Arh 2020,74(3),199-204","journal-title":"Med Arh"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/clc.22395","volume":"38","author":"Lawson W.E.","year":"2015","unstructured":"Lawson W.E.; Hui J.C.; Kennard E.D.; Linnemeier G.; Investigators I-I. enhanced external counterpulsation is cost-effective in reducing hospital costs in refractory angina patients. Clin Cardiol 2015,38,344-349","journal-title":"Clin Cardiol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/eurjcn\/zvab040","volume":"21","author":"Wu E.","year":"2022","unstructured":"Wu E.; M\u00e5rtensson J.; Desta L.; Brostr\u00f6m A.; Adverse events and their management during enhanced external counterpulsation treatment in patients with refractory angina pectoris: Observations from a routine clinical practice. Eur J Cardiovasc Nurs 2022,21(2),152-160","journal-title":"Eur J Cardiovasc Nurs"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"278","DOI":"10.4103\/aca.ACA_86_18","volume":"22","author":"Ezzati P.","year":"2019","unstructured":"Ezzati P.; Sahebjami F.; Madani F.R.; Komasi S.; Heydarpour B.; Saeidi M.; Ezzati K.; Refractory angina frequencies during 7 weeks treatment by enhanced external counterpulsation in coronary artery disease patients with and without diabetes. Ann Card Anaesth 2019,22(3),278-282","journal-title":"Ann Card Anaesth"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/clc.23516","volume":"44","author":"Wu E.","year":"2021","unstructured":"Wu E.; M\u00e5rtensson J.; Desta L.; Brostr\u00f6m A.; Predictors of treatment benefits after enhanced external counterpulsation in patients with refractory angina pectoris. Clin Cardiol 2021,44(2),160-167","journal-title":"Clin Cardiol"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/1440-1681.12263","volume":"41","author":"Beck D.T.","year":"2014","unstructured":"Beck D.T.; Martin J.S.; Casey D.P.; Avery J.C.; Sardina P.D.; Braith R.W.; Enhanced external counterpulsation improves endothelial function and exercise capacity in patients with ischaemic left ventricular dysfunction. Clin Exp Pharmacol Physiol 2014,41(9),628-636","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.5414\/CN108096","volume":"82","author":"Wu C.K.","year":"2014","unstructured":"Wu C.K.; Hung H.F.; Leu J.G.; Tarng D.C.; Tsai M.H.; Chiang S.S.; The immediate and one-year outcomes of dialysis patients with refractory angina treated by enhanced external counterpulsation. Clin Nephrol 2014,82(1),34-40","journal-title":"Clin Nephrol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1056\/NEJMoa1402556","volume":"372","author":"Verheye S.","year":"2015","unstructured":"Verheye S.; Jolic\u0153ur E.M.; Behan M.W.; Pettersson T.; Sainsbury P.; Hill J.; Vrolix M.; Agostoni P.; Engstrom T.; Labinaz M.; de Silva R.; Schwartz M.; Meyten N.; Uren N.G.; Doucet S.; Tanguay J.F.; Lindsay S.; Henry T.D.; White C.J.; Edelman E.R.; Banai S.; Efficacy of a device to narrow the coronary sinus in refractory angina. N Engl J Med 2015,372(6),519-527","journal-title":"N Engl J Med"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ijcard.2021.05.034","volume":"337","author":"Ponticelli F.","year":"2021","unstructured":"Ponticelli F.; Khokhar A.A.; Leenders G.; Konigstein M.; Zivelonghi C.; Agostoni P.; van Kuijk J.P.; Ajmi I.; Lindsay S.; Bunc M.; Tebaldi M.; Cafaro A.; Cheng K.; Ielasi A.; Patterson T.; Wolter J.S.; Sgura F.; De Marco F.; Ioanes D.; D\u2019Amico G.; Ciardetti M.; Berti S.; Guarracini S.; Di Mauro M.; Gallone G.; Dekker M.; Silvis M.J.M.; Tarantini G.; Redwood S.; Colombo A.; Liebetrau C.; de Silva R.; Rapezzi C.; Ferrari R.; Campo G.; Schnupp S.; Timmers L.; Verheye S.; Stella P.; Banai S.; Giannini F.; Safety and efficacy of coronary sinus narrowing in chronic refractory angina: Insights from the RESOURCE study. Int J Cardiol 2021,337,29-37","journal-title":"Int J Cardiol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1016\/j.jacc.2005.06.079","volume":"46","author":"Leon M.B.","year":"2005","unstructured":"Leon M.B.; Kornowski R.; Downey W.E.; Weisz G.; Baim D.S.; Bonow R.O.; Hendel R.C.; Cohen D.J.; Gervino E.; Laham R.; Lembo N.J.; Moses J.W.; Kuntz R.E.; A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease. J Am Coll Cardiol 2005,46(10),1812-1819","journal-title":"J Am Coll Cardiol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/ner.12349","volume":"19","author":"Eldabe S.","year":"2016","unstructured":"Eldabe S.; Thomson S.; Duarte R.; Brookes M.; deBelder M.; Raphael J.; Davies E.; Taylor R.; The effectiveness and cost-effectiveness of spinal cord stimulation for refractory angina (RASCAL Study): A pilot randomized controlled trial. Neuromodulation 2016,19(1),60-70","journal-title":"Neuromodulation"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s12471-020-01422-0","volume":"28","author":"Vervaat F.E.","year":"2020","unstructured":"Vervaat F.E.; van der Gaag A.; van Suijlekom H.; Botman C.J.; Teeuwen K.; Wijnbergen I.; Improvement in quality of life and angina pectoris: 1-year follow-up of patients with refractory angina pectoris and spinal cord stimulation. Neth Heart J 2020,28(9),478-484","journal-title":"Neth Heart J"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1525-1403.2011.00355.x","volume":"14","author":"Buiten M.S.","year":"2011","unstructured":"Buiten M.S.; DeJongste M.J.L.; Beese U.; Kliphuis C.; Durenkamp A.; Staal M.J.; Subcutaneous electrical nerve stimulation: A feasible and new method for the treatment of patients with refractory angina. Neuromodulation 2011,14(3),258-265","journal-title":"Neuromodulation"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1177\/2049463714549775","volume":"9","author":"Denby C.","year":"2015","unstructured":"Denby C.; Groves D.G.; Eleuteri A.; Tsang H.; Leach A.; Hammond C.; Bridson J.D.; Fisher M.; Elt M.; Laflin R.; Fisher A.C.; Temporary sympathectomy in chronic refractory angina: A randomised, double-blind, placebo-controlled trial. Br J Pain 2015,9(3),142-148","journal-title":"Br J Pain"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1093\/eurheartj\/ehx352","volume":"38","author":"Hartikainen J.","year":"2017","unstructured":"Hartikainen J.; Hassinen I.; Hedman A.; Kivel\u00e4 A.; Saraste A.; Knuuti J.; Husso M.; Mussalo H.; Hedman M.; Rissanen T.T.; Toivanen P.; Heikura T.; Witztum J.L.; Tsimikas S.; Yl\u00e4-Herttuala S.; Adenoviral intramyocardial VEGF-D gene transfer increases myocardial perfusion reserve in refractory angina patients: A phase I\/IIa study with 1-year follow-up. Eur Heart J 2017,38(33),2547-2555","journal-title":"Eur Heart J"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jacc.2007.06.010","volume":"50","author":"Henry T.D.","year":"2007","unstructured":"Henry T.D.; Grines C.L.; Watkins M.W.; Dib N.; Barbeau G.; Moreadith R.; Andrasfay T.; Engler R.L.; Effects of Ad5FGF-4 in patients with angina: An analysis of pooled data from the AGENT-3 and AGENT-4 trials. J Am Coll Cardiol 2007,50(11),1038-1046","journal-title":"J Am Coll Cardiol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1097\/CCM.0000000000001138","volume":"43","author":"Lee F.Y.","year":"2015","unstructured":"Lee F.Y.; Chen Y.L.; Sung P.H.; Ma M.C.; Pei S.N.; Wu C.J.; Yang C.H.; Fu M.; Ko S.F.; Leu S.; Yip H.K.; Intracoronary transfusion of circulation-derived CD34+ cells improves left ventricular function in patients with end-stage diffuse coronary artery disease unsuitable for coronary intervention. Crit Care Med 2015,43(10),2117-2132","journal-title":"Crit Care Med"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"e010802","DOI":"10.1161\/CIRCINTERVENTIONS.121.010802","volume":"15","author":"Henry T.D.","year":"2022","unstructured":"Henry T.D.; Bairey Merz C.N.; Wei J.; Corban M.T.; Quesada O.; Joung S.; Kotynski C.L.; Wang J.; Lewis M.; Schumacher A.M.; Bartel R.L.; Takagi H.; Shah V.; Lee A.; Sietsema W.K.; Losordo D.W.; Lerman A.; Autologous CD34+ stem cell therapy increases coronary flow reserve and reduces angina in patients with coronary microvascular dysfunction. Circ Cardiovasc Interv 2022,15(2),e010802","journal-title":"Circ Cardiovasc Interv"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1161\/CIRCRESAHA.121.319644","volume":"130","author":"Corban M.T.","year":"2022","unstructured":"Corban M.T.; Toya T.; Albers D.; Sebaali F.; Lewis B.R.; Bois J.; Gulati R.; Prasad A.; Best P.J.M.; Bell M.R.; Rihal C.S.; Prasad M.; Ahmad A.; Lerman L.O.; Solseth M.L.; Winters J.L.; Dietz A.B.; Lerman A.; IMPROvE-CED trial: Intracoronary autologous CD34+ cell therapy for treatment of coronary endothelial dysfunction in patients with angina and nonobstructive coronary arteries. Circ Res 2022,130(3),326-338","journal-title":"Circ Res"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ijcard.2008.03.022","volume":"135","author":"Kronhaus K.D.","year":"2009","unstructured":"Kronhaus K.D.; Lawson W.E.; Enhanced external counterpulsation is an effective treatment for Syndrome X. Int J Cardiol 2009,135(2),256-257","journal-title":"Int J Cardiol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1177\/000331970105201001","volume":"52","author":"Stys T.","year":"2001","unstructured":"Stys T.; Lawson W.E.; Hui J.C.K.; Lang G.; Liuzzo J.; Cohn P.F.; Acute hemodynamic effects and angina improvement with enhanced external counterpulsation. Angiology 2001,52(10),653-658","journal-title":"Angiology"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1540-8191.1987.tb00205.x","volume":"2","author":"Mohl W.","year":"1987","unstructured":"Mohl W.; Coronary sinus interventions: From concept to clinics. J Card Surg 1987,2(4),467-493","journal-title":"J Card Surg"},{"key":"ref=51","first-page":"20","volume":"96","author":"Mohl W.","year":"1984","unstructured":"Mohl W.; The development and rationale of pressure-controlled intermittent coronary sinus occlusion--a new approach to protect ischemic myocardium. Wien Klin Wochenschr 1984,96(1),20-25","journal-title":"Wien Klin Wochenschr"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.carrev.2014.12.004","volume":"16","author":"Mohl W.","year":"2015","unstructured":"Mohl W.; Gangl C.; Jusi\u0107 A.; Aschacher T.; De Jonge M.; Rattay F.; PICSO: From myocardial salvage to tissue regeneration. Cardiovasc Revasc Med 2015,16(1),36-46","journal-title":"Cardiovasc Revasc Med"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0735-1097(85)80437-X","volume":"5","author":"Mohl W.","year":"1985","unstructured":"Mohl W.; Punzengruber C.; Moser M.; Kenner T.; Heimisch W.; Haendchen R.; Meerbaum S.; Maurer G.; Corday E.; Effects of pressure-controlled intermittent coronary sinus occlusion on regional ischemic myocardial function. J Am Coll Cardiol 1985,5(4),939-947","journal-title":"J Am Coll Cardiol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.jtcvs.2006.12.044","volume":"133","author":"Weigel G.","year":"2007","unstructured":"Weigel G.; Kajgana I.; Bergmeister H.; Riedl G.; Glogar H.D.; Gy\u00f6ngy\u00f6si M.; Blasnig S.; Heinze G.; Mohl W.; Beck and back: A paradigm change in coronary sinus interventions-pulsatile stretch on intact coronary venous endothelium. J Thorac Cardiovasc Surg 2007,133(6),1581-1587.e6","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"793","DOI":"10.4252\/wjsc.v7.i5.793","volume":"7","author":"Milasinovic D.","year":"2015","unstructured":"Milasinovic D.; Mohl W.; Contemporary perspective on endogenous myocardial regeneration. World J Stem Cells 2015,7(5),793-805","journal-title":"World J Stem Cells"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1161\/01.RES.85.2.192","volume":"85","author":"Zheng W.","year":"1999","unstructured":"Zheng W.; Brown M.D.; Brock T.A.; Bjercke R.J.; Tomanek R.J.; Bradycardia-induced coronary angiogenesis is dependent on vascular endothelial growth factor. Circ Res 1999,85(2),192-198","journal-title":"Circ Res"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1540-8183.2012.00768.x","volume":"25","author":"Van De Hoef T.P.","year":"2012","unstructured":"Van De Hoef T.P.; Nolte F.; Delewi R.; Henriques J.P.S.; Spaan J.A.; Tijssen J.G.P.; Siebes M.; Wykrzykowska J.J.; Stone G.W.; Piek J.J.; Intracoronary hemodynamic effects of pressure-controlled intermittent coronary sinus occlusion (PICSO): Results from the First-In-Man Prepare PICSO Study. J Interv Cardiol 2012,25(6),549-556","journal-title":"J Interv Cardiol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1253\/circj.72.526","volume":"72","author":"Mohl W.","year":"2007","unstructured":"Mohl W.; Komamura K.; Kasahara H.; Heinze G.; Glogar D.; Hirayama A.; Kodama K.; Myocardial protection via the coronary sinus. Circ J 2007,72(4),526-533","journal-title":"Circ J"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1016\/j.jtcvs.2004.01.036","volume":"127","author":"Syeda B.","year":"2004","unstructured":"Syeda B.; Schukro C.; Heinze G.; Modaressi K.; Glogar D.; Maurer G.; Mohl W.; The salvage potential of coronary sinus interventions: Meta-analysis and pathophysiologic consequences. J Thorac Cardiovasc Surg 2004,127(6),1703-1712","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4244\/EIJY15M03_10","volume":"11","author":"van de Hoef T.P.","year":"2015","unstructured":"van de Hoef T.P.; Nijveldt R.; van der Ent M.; Neunteufl T.; Meuwissen M.; Khattab A.; Berger R.; Kuijt W.J.; Wykrzykowska J.; Tijssen J.G.P.; van Rossum A.C.; Stone G.W.; Piek J.J.; Pressure-controlled intermittent coronary sinus occlusion (PICSO) in acute ST-segment elevation myocardial infarction: Results of the Prepare RAMSES safety and feasibility study. EuroIntervention 2015,11(1),37-44","journal-title":"EuroIntervention"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/ccd.29793","volume":"99","author":"Scarsini R.","year":"2022","unstructured":"Scarsini R.; Terentes-Printzios D.; Shanmuganathan M.; Kotronias R.A.; Borlotti A.; Marin F.; Langrish J.; Lucking A.; Ribichini F.; Kharbanda R.; Ferreira V.M.; Channon K.M.; De Maria G.L.; Banning A.P.; Pressure-controlled intermittent coronary sinus occlusion improves the vasodilatory microvascular capacity and reduces myocardial injury in patients with . Catheter Cardiovasc Interv 2022,99(2),329-339","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ijcard.2017.05.030","volume":"241","author":"Pappalardo F.","year":"2017","unstructured":"Pappalardo F.; Ancona M.B.; Giannini F.; Regazzoli D.; Mangieri A.; Montorfano M.; De Bonis M.; Alfieri O.; Zangrillo A.; Scandroglio A.M.; Colombo A.; Latib A.; First in man prolonged pressure-controlled intermittent coronary sinus occlusion to treat refractory left ventricular dysfunction and ischemia with patent epicardial coronary arteries. Int J Cardiol 2017,241,138-141","journal-title":"Int J Cardiol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"ytac159","DOI":"10.1093\/ehjcr\/ytac159","volume":"6","author":"Giannini F.","year":"2022","unstructured":"Giannini F.; Cuenin L.; Adjedj J.; Impact of the coronary sinus reducer on the coronary artery circulation cases report. Eur Heart J Case Rep 2022,6(6),ytac159","journal-title":"Eur Heart J Case Rep"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s10554-020-01964-9","volume":"37","author":"Palmisano A.","year":"2021","unstructured":"Palmisano A.; Giannini F.; Rancoita P.; Gallone G.; Benedetti G.; Baldetti L.; Tzanis G.; Vignale D.; Monti C.; Ponticelli F.; Ancona M.; Montorfano M.; Del Maschio A.; De Cobelli F.; Colombo A.; Esposito A.; Feature tracking and mapping analysis of myocardial response to improved perfusion reserve in patients with refractory angina treated by coronary sinus Reducer implantation: A CMR study. Int J Cardiovasc Imaging 2021,37(1),291-303","journal-title":"Int J Cardiovasc Imaging"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"e1511","DOI":"10.4244\/EIJ-D-19-00766","volume":"16","author":"Zivelonghi C.","year":"2021","unstructured":"Zivelonghi C.; Konigstein M.; Azzano A.; Agostoni P.; Topilski Y.; Banai S.; Verheye S.; Effects of coronary sinus reducer implantation on oxygen kinetics in patients with refractory angina. EuroIntervention 2021,16(18),e1511-e1517","journal-title":"EuroIntervention"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"e009148","DOI":"10.1161\/CIRCIMAGING.119.009148","volume":"12","author":"Giannini F.","year":"2019","unstructured":"Giannini F.; Palmisano A.; Baldetti L.; Benedetti G.; Ponticelli F.; Rancoita P.M.V.; Ruparelia N.; Gallone G.; Ancona M.; Mangieri A.; Tzanis G.; De Cobelli F.; Del Maschio A.; Colombo A.; Esposito A.; Patterns of regional myocardial perfusion following coronary sinus reducer implantation. Circ Cardiovasc Imaging 2019,12(9),e009148","journal-title":"Circ Cardiovasc Imaging"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/j.jacc.2007.01.061","volume":"49","author":"Banai S.","year":"2007","unstructured":"Banai S.; Ben Muvhar S.; Parikh K.H.; Medina A.; Sievert H.; Seth A.; Tsehori J.; Paz Y.; Sheinfeld A.; Keren G.; Coronary sinus reducer stent for the treatment of chronic refractory angina pectoris: A prospective, open-label, multicenter, safety feasibility first-in-man study. J Am Coll Cardiol 2007,49(17),1783-1789","journal-title":"J Am Coll Cardiol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.cjca.2021.12.009","volume":"38","author":"Hochstadt A.","year":"2022","unstructured":"Hochstadt A.; Itach T.; Merdler I.; Ghantous E.; Ziv-Baran T.; Leshno M.; Banai S.; Konigstein M.; Effectiveness of coronary sinus reducer for treatment of refractory angina: A meta-analysis. Can J Cardiol 2022,38(3),376-383","journal-title":"Can J Cardiol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/clc.23566","volume":"44","author":"Konigstein M.","year":"2021","unstructured":"Konigstein M.; Ponticelli F.; Zivelonghi C.; Merdler I.; Revivo M.; Verheye S.; Giannini F.; Banai S.; Long-term outcomes of patients undergoing coronary sinus reducer implantation - A multicenter study. Clin Cardiol 2021,44(3),424-428","journal-title":"Clin Cardiol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"561","DOI":"10.4244\/EIJ-D-20-00873","volume":"17","author":"Verheye S.","year":"2021","unstructured":"Verheye S.; Agostoni P.; Giannini F.; Hill J.M.; Jensen C.; Lindsay S.; Stella P.R.; Redwood S.; Banai S.; Konigstein M.; Coronary sinus narrowing for the treatment of refractory angina: a multicentre prospective open-label clinical study (the REDUCER-I study). EuroIntervention 2021,17(7),561-568","journal-title":"EuroIntervention"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1016\/j.jacc.2018.09.061","volume":"72","author":"Parikh P.","year":"2018","unstructured":"Parikh P.; Bhatt P.; Shah D.; Thakar P.; Naik A.; Baxi H.; Banai S.; Parikh K.; First-in-human use of coronary sinus reducer in patients with refractory angina. J Am Coll Cardiol 2018,72(24),3227-3228","journal-title":"J Am Coll Cardiol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.amjcard.2020.03.042","volume":"126","author":"Zivelonghi C.","year":"2020","unstructured":"Zivelonghi C.; Verheye S.; Timmers L.; van Kuijk J.P.; Giannini F.; Dekker M.; Silvis M.; Abawi M.; Leenders G.; Kortland F.; Tzanis G.; Beneduce A.; Benfari G.; Stella P.; Henriques J.P.S.; Banai S.; Agostoni P.; Efficacy of coronary sinus reducer in patients with non-revascularized chronic total occlusions. Am J Cardiol 2020,126,1-7","journal-title":"Am J Cardiol"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"E884","DOI":"10.25270\/jic\/22.00643","volume":"33","author":"Ponticelli F.","year":"2021","unstructured":"Ponticelli F.; Khokhar A.A.; Albani S.; Tzanis G.; Gallo F.; Guarracini S.; Banai S.; Colombo A.; Giannini F.; Insights into coronary sinus reducer non-responders. J Invasive Cardiol 2021,33(11),E884-E889","journal-title":"J Invasive Cardiol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"ytac210","DOI":"10.1093\/ehjcr\/ytac210","volume":"6","author":"Picchi A.","year":"2022","unstructured":"Picchi A.; Misuraca L.; Calabria P.; Limbruno U.; Double reducer implantation in the coronary venous system for treatment of refractory angina: A case report. Eur Heart J Case Rep 2022,6(6),ytac210","journal-title":"Eur Heart J Case Rep"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/pace.14367","volume":"45","author":"Khalaph M.","year":"2022","unstructured":"Khalaph M.; Bergau L.; Vanezi M.; Rudolph T.K.; Sommer P.; Sohns C.; Beneficial effects of atrial fibrillation ablation in patients with angina pectoris and coronary sinus reducer. Pacing Clin Electrophysiol 2022,45(1),149-153","journal-title":"Pacing Clin Electrophysiol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s00380-021-01909-9","volume":"37","author":"Vescovo G.M.","year":"2022","unstructured":"Vescovo G.M.; Zivelonghi C.; Agostoni P.; Dekker M.; Silvis M.; Leenders G.; van Kuijk J.P.; Timmers L.; Stella P.; Banai S.; Verheye S.; Efficacy of coronary sinus Reducer in patients with refractory angina and diabetes mellitus. Heart Vessels 2022,37(2),194-199","journal-title":"Heart Vessels"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1161\/01.CIR.0000148849.51177.97","volume":"110","author":"Nishida T.","year":"2004","unstructured":"Nishida T.; Shimokawa H.; Oi K.; Tatewaki H.; Uwatoku T.; Abe K.; Matsumoto Y.; Kajihara N.; Eto M.; Matsuda T.; Yasui H.; Takeshita A.; Sunagawa K.; Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo. Circulation 2004,110(19),3055-3061","journal-title":"Circulation"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12947-019-0163-1","volume":"17","author":"\u010celutkien\u0117 J.","year":"2019","unstructured":"\u010celutkien\u0117 J.; Burneikait\u0117 G.; Shkolnik E.; Jakutis G.; Vajauskas D.; \u010cerlinskait\u0117 K.; Zuozien\u0117 G.; Petrauskien\u0117 B.; Puronait\u0117 R.; Komiagien\u0117 R.; Butkuvien\u0117 I.; Stepon\u0117nien\u0117 R.; Misi\u016bra J.; Laucevi\u010dius A.; The effect of cardiac shock wave therapy on myocardial function and perfusion in the randomized, triple-blind, sham-procedure controlled study. Cardiovasc Ultrasound 2019,17(1),13","journal-title":"Cardiovasc Ultrasound"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/MCA.0b013e32834e4fa5","volume":"23","author":"Zuozien\u0117 G.","year":"2012","unstructured":"Zuozien\u0117 G.; Laucevi\u010dius A.; Leibowitz D.; Extracorporeal shockwave myocardial revascularization improves clinical symptoms and left ventricular function in patients with refractory angina. Coron Artery Dis 2012,23(1),62-67","journal-title":"Coron Artery Dis"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.mayocp.2013.11.017","volume":"89","author":"Cassar A.","year":"2014","unstructured":"Cassar A.; Prasad M.; Rodriguez-Porcel M.; Reeder G.S.; Karia D.; DeMaria A.N.; Lerman A.; Safety and efficacy of extracorporeal shock wave myocardial revascularization therapy for refractory angina pectoris. Mayo Clin Proc 2014,89(3),346-354","journal-title":"Mayo Clin Proc"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/MCA.0000000000000218","volume":"26","author":"Prasad M.","year":"2015","unstructured":"Prasad M.; Wan Ahmad W.A.; Sukmawan R.; Magsombol E.B.L.; Cassar A.; Vinshtok Y.; Ismail M.D.; Mahmood Zuhdi A.S.; Locnen S.A.; Jimenez R.; Callleja H.; Lerman A.; Extracorporeal shockwave myocardial therapy is efficacious in improving symptoms in patients with refractory angina pectoris \u2013 a multicenter study. Coron Artery Dis 2015,26(3),194-200","journal-title":"Coron Artery Dis"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.carrev.2017.05.006","volume":"18","author":"Alunni G.","year":"2017","unstructured":"Alunni G.; Barbero U.; Vairo A.; D\u2019Amico S.; Pianelli M.; Zema D.; Bongiovanni F.; Gaita F.; The beneficial effect of extracorporeal shockwave myocardial revascularization: Two years of follow-up. Cardiovasc Revasc Med 2017,18(8),572-576","journal-title":"Cardiovasc Revasc Med"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"567","DOI":"10.23736\/S0026-4725.20.05110-5","volume":"68","author":"Alunni G.","year":"2020","unstructured":"Alunni G.; D\u2019Amico S.; Castelli C.; De Lio G.; Fioravanti F.; Gallone G.; Marra S.; De Ferrari G.M.; Impact of extracorporeal shockwave myocardial revascularization on the ischemic burden of refractory angina patients: A single photon emission computed tomography study. Minerva Cardioangiol 2020,68(6),567-576","journal-title":"Minerva Cardioangiol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.echo.2019.04.420","volume":"32","author":"Ceccon C.L.","year":"2019","unstructured":"Ceccon C.L.; Duque A.S.; Gowdak L.H.; Mathias W.; Chiang H.P.; Sbano J.C.N.; Lima M.F.; Machado Cesar L.A.; Cruz C.B.B.V.; Dourado P.M.M.; Meneghetti C.; Tsutsui J.M.; Shock-wave therapy improves myocardial blood flow reserve in patients with refractory angina: Evaluation by real-time myocardial perfusion echocardiography. J Am Soc Echocardiogr 2019,32(9),1075-1085","journal-title":"J Am Soc Echocardiogr"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1007\/s12350-021-02768-7","volume":"29","author":"Jia N.","year":"2022","unstructured":"Jia N.; Zhang R.; Liu B.; Liu B.; Qi X.; Lan M.; Liu J.; Zeng P.; Chen C.; Li W.; Guo Y.; Yao Z.; He Q.; Efficacy and safety of cardiac shock wave therapy for patients with severe coronary artery disease: A randomized, double-blind control study. J Nucl Cardiol 2022,29(5),2404-2419","journal-title":"J Nucl Cardiol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/MCA.0000000000000648","volume":"29","author":"Shkolnik E.","year":"2018","unstructured":"Shkolnik E.; Burneikaite G.; Jakutis G.; Scherbak M.; Zuoziene G.; Petrauskiene B.; Trush E.; Vasyuk Y.; Laucevicius A.; Celutkiene J.; A randomized, triple-blind trial of cardiac shock-wave therapy on exercise tolerance and symptoms in patients with stable angina pectoris. Coron Artery Dis 2018,29(7),579-586","journal-title":"Coron Artery Dis"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"CD003712","DOI":"10.1002\/14651858.CD003712.pub3","volume":"2015","author":"Briones E.","year":"2015","unstructured":"Briones E.; Lacalle J.R.; Marin-Leon I.; Rueda J.R.; Transmyocardial laser revascularization versus medical therapy for refractory angina. Cochrane Libr 2015,2015(2),CD003712","journal-title":"Cochrane Libr"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/cphy.c140032","volume":"5","author":"Foreman R.D.","year":"2015","unstructured":"Foreman R.D.; Garrett K.M.; Blair R.W.; Mechanisms of cardiac pain. Compr Physiol 2015,5(2),929-960","journal-title":"Compr Physiol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1093\/oxfordjournals.eurheartj.a060226","volume":"13","author":"Sanderson J.E.","year":"1992","unstructured":"Sanderson J.E.; Brooksby P.; Waterhouse D.; Palmer R.B.G.; Neubauer K.; Epidural spinal electrical stimulation for severe angina: A study of its effects on symptoms, exercise tolerance and degree of ischaemia. Eur Heart J 1992,13(5),628-633","journal-title":"Eur Heart J"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"e12855","DOI":"10.14814\/phy2.12855","volume":"4","author":"Smith F.M.","year":"2016","unstructured":"Smith F.M.; Vermeulen M.; Cardinal R.; Long-term spinal cord stimulation modifies canine intrinsic cardiac neuronal properties and ganglionic transmission during high-frequency repetitive activation. Physiol Rep 2016,4(13),e12855","journal-title":"Physiol Rep"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.ijcard.2016.10.105","volume":"227","author":"Imran T.F.","year":"2017","unstructured":"Imran T.F.; Malapero R.; Qavi A.H.; Hasan Z.; de la Torre B.; Patel Y.R.; Yong R.J.; Djousse L.; Gaziano J.M.; Gerhard-Herman M.D.; Efficacy of spinal cord stimulation as an adjunct therapy for chronic refractory angina pectoris. Int J Cardiol 2017,227,535-542","journal-title":"Int J Cardiol"},{"key":"ref=92","doi-asserted-by":"publisher","author":"Vervaat F.E.","unstructured":"Vervaat F.E.; van Suijlekom H.; Wijnbergen I.F.; Single-center experience with high-density spinal cord stimulation in patients with refractory angina pectoris. Neuromodulation 2022; S1094-7159(22): 01367-8.","DOI":"10.1016\/j.neurom.2022.11.006"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.rapm.2006.02.001","volume":"31","author":"Goroszeniuk T.","year":"2006","unstructured":"Goroszeniuk T.; Kothari S.; Hamann W.; Subcutaneous neuromodulating implant targeted at the site of pain. Reg Anesth Pain Med 2006,31(2),168-171","journal-title":"Reg Anesth Pain Med"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1510\/icvts.2005.118976","volume":"5","author":"Stritesky M.","year":"2006","unstructured":"Stritesky M.; Dobias M.; Demes R.; Semrad M.; Poliachova E.; Cermak T.; Charvat J.; Malek I.; Endoscopic thoracic sympathectomy - its effect in the treatment of refractory angina pectoris. Interact Cardiovasc Thorac Surg 2006,5(4),464-468","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"e1332","DOI":"10.4244\/EIJ-D-18-00144","volume":"14","author":"Sharma R.","year":"2018","unstructured":"Sharma R.; Sharma S.; Fuster V.; Coronary vasospastic angina: A rare case of ergonovine positivity and curative bilateral cardiac sympathectomy. EuroIntervention 2018,14(12),e1332-e1333","journal-title":"EuroIntervention"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1056\/NEJM198407053110106","volume":"311","author":"Wilkinson H.A.","year":"1984","unstructured":"Wilkinson H.A.; Radiofrequency percutaneous upper-thoracic sympathectomy. Technique and review of indications. N Engl J Med 1984,311(1),34-36","journal-title":"N Engl J Med"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"ytab184","DOI":"10.1093\/ehjcr\/ytab184","volume":"5","author":"Hudec M.","year":"2021","unstructured":"Hudec M.; Jiravsky O.; Spacek R.; Neuwirth R.; Knybel L.; Sknouril L.; Cvek J.; Miklik R.; Chronic refractory angina pectoris treated by bilateral stereotactic radiosurgical stellate ganglion ablation: First-in-man case report. Eur Heart J Case Rep 2021,5(8),ytab184","journal-title":"Eur Heart J Case Rep"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.jpainsymman.2019.05.019","volume":"58","author":"Tan Z.","year":"2019","unstructured":"Tan Z.; Nalpon J.; Valchanov K.; Case series of left stellate ganglion blocks for refractory angina pectoris: 14 years later and still efficacious. J Pain Symptom Manage 2019,58(3),e11-e14","journal-title":"J Pain Symptom Manage"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1161\/01.CIR.98.25.2800","volume":"98","author":"Losordo D.W.","year":"1998","unstructured":"Losordo D.W.; Vale P.R.; Symes J.F.; Dunnington C.H.; Esakof D.D.; Maysky M.; Ashare A.B.; Lathi K.; Isner J.M.; Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 1998,98(25),2800-2804","journal-title":"Circulation"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jacc.2004.12.068","volume":"45","author":"Kastrup J.","year":"2005","unstructured":"Kastrup J.; J\u00f8rgensen E.; R\u00fcck A.; T\u00e4gil K.; Glogar D.; Ruzyllo W.; B\u00f8tker H.E.; Dudek D.; Drvota V.; Hesse B.; Thuesen L.; Blomberg P.; Gy\u00f6ngy\u00f6si M.; Sylv\u00e9n C.; Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris. J Am Coll Cardiol 2005,45(7),982-988","journal-title":"J Am Coll Cardiol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1161\/01.CIR.103.17.2138","volume":"103","author":"Vale P.R.","year":"2001","unstructured":"Vale P.R.; Losordo D.W.; Milliken C.E.; McDonald M.C.; Gravelin L.M.; Curry C.M.; Esakof D.D.; Maysky M.; Symes J.F.; Isner J.M.; Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation 2001,103(17),2138-2143","journal-title":"Circulation"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41434-021-00295-1","volume":"29","author":"Leikas A.J.","year":"2022","unstructured":"Leikas A.J.; Hassinen I.; Hedman A.; Kivel\u00e4 A.; Yl\u00e4-Herttuala S.; Hartikainen J.E.K.; Long-term safety and efficacy of intramyocardial adenovirus-mediated VEGF-D gene therapy eight-year follow-up of phase I KAT301 study. Gene Ther 2022,29(5),289-293","journal-title":"Gene Ther"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/S0735-1097(03)00988-4","volume":"42","author":"Grines C.L.","year":"2003","unstructured":"Grines C.L.; Watkins M.W.; Mahmarian J.J.; Iskandrian A.E.; Rade J.J.; Marrott P.; Pratt C.; Kleiman N.; A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina. J Am Coll Cardiol 2003,42(8),1339-1347","journal-title":"J Am Coll Cardiol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1161\/hc1102.105595","volume":"105","author":"Grines C.L.","year":"2002","unstructured":"Grines C.L.; Watkins M.W.; Helmer G.; Penny W.; Brinker J.; Marmur J.D.; West A.; Rade J.J.; Marrott P.; Hammond H.K.; Engler R.L.; Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris. Circulation 2002,105(11),1291-1297","journal-title":"Circulation"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1161\/CIRCULATIONAHA.106.644518","volume":"114","author":"Kawamoto A.","year":"2006","unstructured":"Kawamoto A.; Iwasaki H.; Kusano K.; Murayama T.; Oyamada A.; Silver M.; Hulbert C.; Gavin M.; Hanley A.; Ma H.; Kearney M.; Zak V.; Asahara T.; Losordo D.W.; CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells. Circulation 2006,114(20),2163-2169","journal-title":"Circulation"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.3727\/096368916X691484","volume":"25","author":"Henry T.D.","year":"2016","unstructured":"Henry T.D.; Schaer G.L.; Traverse J.H.; Povsic T.J.; Davidson C.; Lee J.S.; Costa M.A.; Bass T.; Mendelsohn F.; Fortuin F.D.; Pepine C.J.; Patel A.N.; Riedel N.; Junge C.; Hunt A.; Kereiakes D.J.; White C.; Harrington R.A.; Schatz R.A.; Losordo D.W.; Autologous CD34 cell therapy for refractory angina: 2-Year outcomes from the ACT34-CMI study. Cell Transplant 2016,25(9),1701-1711","journal-title":"Cell Transplant"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/j.jcin.2016.05.003","volume":"9","author":"Povsic T.J.","year":"2016","unstructured":"Povsic T.J.; Henry T.D.; Traverse J.H.; Fortuin F.D.; Schaer G.L.; Kereiakes D.J.; Schatz R.A.; Zeiher A.M.; White C.J.; Stewart D.J.; Jolicoeur E.M.; Bass T.; Henderson D.A.; Dignacco P.; Gu Z.; Al-Khalidi H.R.; Junge C.; Nada A.; Hunt A.S.; Losordo D.W.; The RENEW trial. JACC Cardiovasc Interv 2016,9(15),1576-1585","journal-title":"JACC Cardiovasc Interv"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"e411","DOI":"10.1097\/CCM.0000000000003051","volume":"46","author":"Sung P.H.","year":"2018","unstructured":"Sung P.H.; Lee F.Y.; Tong M.S.; Chiang J.Y.; Pei S.N.; Ma M.C.; Li Y.C.; Chen Y.L.; Wu C.J.; Sheu J.J.; Lee M.S.; Yip H.K.; The five-year clinical and angiographic follow-up outcomes of intracoronary transfusion of circulation-derived CD34+ cells for patients with end-stage diffuse coronary artery disease unsuitable for coronary intervention-phase I clinical trial. Crit Care Med 2018,46(5),e411-e418","journal-title":"Crit Care Med"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1002\/sctm.20-0046","volume":"9","author":"Johnson G.L.","year":"2020","unstructured":"Johnson G.L.; Henry T.D.; Povsic T.J.; Losordo D.W.; Garberich R.F.; Stanberry L.I.; Strauss C.E.; Traverse J.H.; CD34 cell therapy significantly reduces adverse cardiac events, health care expenditures, and mortality in patients with refractory angina. Stem Cells Transl Med 2020,9(10),1147-1152","journal-title":"Stem Cells Transl Med"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"106906","DOI":"10.1016\/j.vph.2021.106906","volume":"141","author":"Theofilis P.","year":"2021","unstructured":"Theofilis P.; Oikonomou E.; Vogiatzi G.; Antonopoulos A.S.; Siasos G.; Iliopoulos D.C.; Perrea D.; Tsioufis C.; Tousoulis D.; The impact of proangiogenic microRNA modulation on blood flow recovery following hind limb ischemia. A systematic review and meta-analysis of animal studies. Vascul Pharmacol 2021,141,106906","journal-title":"Vascul Pharmacol"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/cvr\/cvw235","volume":"113","author":"Rawal S.","year":"2017","unstructured":"Rawal S.; Munasinghe P.E.; Shindikar A.; Paulin J.; Cameron V.; Manning P.; Williams M.J.A.; Jones G.T.; Bunton R.; Galvin I.; Katare R.; Down-regulation of proangiogenic microRNA-126 and microRNA-132 are early modulators of diabetic cardiac microangiopathy. Cardiovasc Res 2017,113(1),90-101","journal-title":"Cardiovasc Res"},{"key":"ref=112","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.2174\/0929867329666220830100530","volume":"30","author":"Theofilis P.","year":"2022","unstructured":"Theofilis P.; Oikonomou E.; Vogiatzi G.; The role of microRNA-126 in atherosclerotic cardiovascular diseases. Curr Med Chem 2022,30(17),1902-1921","journal-title":"Curr Med Chem"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"724465","DOI":"10.3389\/fmolb.2021.724465","volume":"8","author":"Theofilis P.","year":"2021","unstructured":"Theofilis P.; Vogiatzi G.; Oikonomou E.; Gazouli M.; Siasos G.; Katifelis H.; Perrea D.; Vavuranakis M.; Iliopoulos D.C.; Tsioufis C.; Tousoulis D.; The effect of MicroRNA-126 mimic administration on vascular perfusion recovery in an animal model of hind limb ischemia. Front Mol Biosci 2021,8,724465","journal-title":"Front Mol Biosci"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3390\/biomedicines8080285","volume":"8","author":"Rakhimov K.","year":"2020","unstructured":"Rakhimov K.; Gori T.; Non-pharmacological treatment of refractory angina and microvascular angina. Biomedicines 2020,8(8),285","journal-title":"Biomedicines"}],"container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612829666230512152153","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/216877\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612829666230512152153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,20]],"date-time":"2024-10-20T10:00:40Z","timestamp":1729418440000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/216877\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,6]]},"references-count":114,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2023,9,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612829666230512152153","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-01-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}